Cloudy after mixing
Crucially, that filing is for CagriSema, not for standalone cagrilintide, and no version is approved yet
Endocrinol Metab Clin N Am 41(351-74):vii Powell DR, Durham SK, Liu F, Baker BK, Lee PD, Watkins SL, Campbell PG, Brewer ED, Hintz RL, Hogg RJ (1998) The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the southwest pediatric nephrology study group
A: This product is not medicated
On top of that, the injectable form carries the same practical drawbacks as other injectable peptides: needles, sterile reconstitution, refrigeration, degradation after mixing, and the ongoing friction of maintaining a regular injection routine for benefits that build gradually over months
Strength protocols often combine growth hormone peptides with healing compounds